Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024
Aisling Vaughan, Mohammed Afzal, Priyanka Nannapaneni, Mathias Leroy, Xanthi Andrianou, Jeffrey Pires, Silvia Funke, Celine Roman, Juliana Reyes‐Urueña, Stephan W. Aberle, Aristos Aristodimou, Guðrún Aspelund, Kirsty F. Bennet, Antra Bormane, Anna Caraglia, Hannah Charles, Émilie Chazelle, Iva Christova, Orna Cohen, Costas S. Constantinou, Simon Couvreur, Asunción Díaz, K Fabiánová, Federica Ferraro, Marte Petrikke Grenersen, Eva Grilc, Tuula Hannila‐Handelberg, Anne Kathrine Hvass, Derval Igoe, Klaus Jansen, Denisa Janţă, Styliani Kaoustou, Anders Koch, Mirjana Lana Kosanović Ličina, Stefka Krumova, Anton Labutin, Raskit Lachmann, Amaryl Lecompte, Remi G. Lefrancois, Viktorija Leitēna, Kirsi Liitsola, Ivan Mlinarić, Zohar Mor, Martha Neary, Alina Novacek, Magnus Wenstøp Øgle, Hana Orlíková, Kalliopi Papadima, Moa Rehn, Małgorzata Sadkowska-Todys, Anca Sîrbu, Klara Sondén, Berta Suárez, Maríanna Þórðardóttir, Paula Vasconcelos, João Vieira Martins, Karolina Zakrzewska, Marc‐Alain Widdowson, Céline M Gossner
Abstract
During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.